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S St tu ud dy y D De es si ig gn n:: To analyze the expression profile of tumor endothelial marker 7 (TEM7) in the spinal cord and dorsal root
ganglion (DRG).
P Pu ur rp po os se e:: To investigate the expression profile of TEM7 in the spinal cord and DRG of adult and developing rats.
O Ov ve er rv vi ie ew w o of f L Li it te er ra at tu ur re e:: Tumor endothelial marker 7 (TEM7) is a putative transmembrane protein that is highly expressed
in the tumor endothelium and in cerebellar neurons.
M Me et th ho od ds s:: In the present study, the expression profile of TEM7 in the spinal cord and DRG of the rat was investigated using
in situ hybridization and immunohistochemical analysis. In addition, the secreted recombinant ectodomain of TEM7 was
employed to label the expression of a putative ligand of TEM7 in the spinal cord and DRG.
R Re es su ul lt ts s:: Specific TEM7 mRNA localization was observed in the motor neurons of the spinal cord and sensory neurons of
the DRG. Glial cells and vascular endothelial cells did not show hybridization signals. Immunohistochemical analysis with a
specific polyclonal antibody revealed a similar localization profile for TEM7 mRNA expression. In the spinal cord, weak
labeling was observed in the gray matter. The TEM7 ectodomain localized the expression of a putative ligand of TEM7 in
the neurilemmal structures and perineurium of the spinal nerve roots. In the DRG, ligand labeling was observed in the
endoneurium and perineurium of the spinal nerves, and extracellular matrix around the sensory neurons. A developmental
study has shown that TEM7 mRNA expression in the motor neurons of the spinal cord and DRG increased with age dur-
ing postnatal development.
C Co on nc cl lu us si io on n:: These findings indicate that TEM7 plays a role as a transmembrane receptor in neuronal populations of the
spinal cord and DRG. 
K Ke ey y W Wo or rd ds s:: Tumor endothelial marker, Spinal cord, Dorsal root ganglion, Ligand
Introduction
Tumor endothelial markers (TEMs) are a group of cell
surface proteins specifically expressed in the endothelium
of various cancers, but are not expressed in normal endothe-
lial tissues
1-3. The limited expression profile of TEMs in the
tumor endothelium indicates specific and restricted func-
tions of the proteins in tumor angiogenesis
2. TEMs associat-
ed with the cell surface are particularly of interest in that
cell surface targets are directly accessible via the blood
stream for functional intervention.
Several recent studies have showed evidence implicating
a role of TEMs in normal tissues. For example, TEM1 is the
lectin-like cell surface protein endosialin that is normally
expressed in several peripheral tissues
2, and TEM8 has been
recently identified as the receptor for anthrax toxin
4. It is
also known that the mouse homologues of TEM1, TEM5
and TEM8 are abundantly expressed in the endothelium of
the embryonic liver
2. Therefore, it appears that TEMs par-
ticipate in a normal physiological process as well as in
tumor angiogenesis.Among the uncharacterized TEMs, TEM7 is a single
transmembrane protein that contains the plexin-semaphorin-
integrin (PSI) domain in its presumptive extracellular
region
2. The PSI domain is mainly found in cell surface pro-
teins of the nervous system, such as semaphorin and its
receptor, plexin. The semaphorin family is a major repellent
that regulates axon guidance and neuronal migration in the
developing nervous system
5,6. Interestingly, these neuronal
guidance molecules having a PSI domain play an important
role outside the nervous system, especially in the vascular
system. For example, it was recently reported that sema-
phorin-3F and its receptor, neuropilin, regulate angiogenesis
in vitro and in vivo
7-10. Reversely, certain angiogenic factors
appear to have an important function in the nervous system.
For example, VEGF is known to regulate neuronal cell
migration, neurite maturation and neurogenesis
11-13. In terms
of TEM7, Carson-Walter et al.
2, recently demonstrated the
presence of TEM7 mRNA in cerebellar Purkinje cells of the
mouse brain, implicating a possible role of the endothelial
protein, TEM7, in the nervous system. In the present study,
to determine the expression profile and function of TEM7
in the spinal nerves, the histochemical localization of TEM7
in the spinal cord and dorsal root ganglion (DRG) of devel-
oping rats and adult rats was investigated.
The PSI domain, which was originally considered as a part
of the sema domain, is found in several transmembrane pro-
teins
14. Even though the presumptive function of the PSI
domain is protein binding
14,15, biological evidence for a func-
tion of the PSI domain is still lacking. Most PSI proteins are
type I transmembrane proteins that function as receptors or
secreted ligands. The predicted structure of TEM7 suggests
that it is also a type I transmembrane protein with a large
extracellular region (ectodomain), a hydrophobic transmem-
brane domain, and a short cytoplasmic tail
2. A secreted form
of the ectodomain of type I transmembrane proteins fused
with a tag has been created to localize the expression of the
corresponding ligands of the transmembrane proteins
16. The
present study employed the same strategy to analyze the
expression profile of a putative ligand of TEM7 in the spinal
cord and DRG using a recombinant TEM7 ectodomain.
Materials and Methods
1. cRNA probes and in situ hybridization immunohis-
tochemistry
For producing a TEM7 cRNA probe, a cDNA fragment
of rat TEM7 was used as a template. The plasmid contain-
ing the fragment of rat TEM7 cDNA was linearized at NcoI
or SalI sites located in the polylinker for antisense and sense
probes, respectively. 
Labeling of RNA probes with digoxigenin-11-UTP (DIG-
11-UTP) was performed using an in vitro transcription kit
(Roche Diagnostics). The amount and size of the transcribed
cRNA were estimated with RNA gel electrophoresis.
In situ hybridization was performed as previously
described with minor modifications
17,18. Briefly, frozen
spinal cords of adult Sprague-Dawley rats (p50~70, n=10)
were sectioned at 18 μ m thicknesses on a cryostat (Leica).
For developmental analysis, Sprague-Dawley rat pups
(n=12 in total) were sacrificed at postnatal day 3, 10, and
20. The spinal cord and DRG were carefully dissected
under a stereomicroscope (Olympus), and the central and
peripheral branches of the DRG were removed with a fine
scissor. The damaged DRG was discarded, and the intact
DRG and spinal cord were frozen with dry ice. Frozen sec-
tions were prepared with the cryostat, and the sections were
fixed in 4% paraformaldehyde (PFA) for 10 minutes,
washed three times with phosphate buffered saline (PBS),
and finally acetylated for 10 minutes. After prehybridiza-
tion, the sections were incubated with hybridization buffer
(50% formamide, 4×SSC, 0.1% CHAPS, 5 mM Na2EDTA,
0.1% Tween-20, 1.25×Denhartdt’s, 125 μ g/mL yeast tRNA,
50 μ g/mL heparin, 200 ng digoxigenin-labeled probes) for 18
hours at 57℃. Non-specific hybridized proteins were
removed by washing in 2×SSC for 10 minutes and with
RNase A (10 μ g/mL), treatment), followed by a final washing
step in 0.1×SSC at 57℃ for 15 minutes. For immunological
detection of digoxigenin-labeled hybrids, the sections were
incubated with anti-digoxigenin alkaline phosphatase
(1:1500; Roche Diagnostics) for 1 hour, and the color reac-
tion was carried out with 4-nitroblue tetrazolium chloride
(NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP).
Sections were dehydrated and were mounted with Crystal-
mount.
2. Molecular cloning of the TEM7 ectodomain
The ectodomain of human TEM7 (24aa-412aa) was gen-
erated using the polymerase chain reaction (PCR) with a
human TEM7 cDNA template (a gift from Dr. B. Vogel-
stein). The sense PCR primers contained an SfiI site where-
as the antisense primers had HindIII sites. After restriction
enzyme digestion, the PCR fragments were inserted into the
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phosphatase (AP), Myc and His as expression tags.
3. Expression and purification of the TEM7 ectodomain
HEK 293 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum and antibiotics. The cells were transfected
with 10 μ g of the expression vectors by the calcium phos-
phate method. The conditioned medium and transfected
cells were harvested two days after transfection, and were
solubilized with 2×sodium dodecyl sulfate (SDS) loading
dye. The samples were subjected to SDS polyacrylamide
gel electrophoresis and were transferred onto a nitrocellu-
lose membrane (Hybond-ECL, Amersham). After blocking
in 5% non-fat milk in phosphate-buffered saline (PBS) con-
taining 0.05% Tween 20 (PBST), the same membranes
were incubated with anti-His or anti-Myc antibodies
overnight at 4℃. Next, the membranes were incubated with
horseradish peroxidase conjugated anti-mouse or anti-rabbit
IgG (1:3000; Amersham) for 1 h at room temperature. An
enhanced chemiluminescence reaction (Amersham) was
performed to visualize the reaction, and the blot was ana-
lyzed using a luminescent image analyzer (LAS-3000; Sci-
ence Lab).
Individual AP fusion proteins were purified with nickel-
nitrilotriacetic acid beads. Conditioned medium from the
transfected HEK 293 cells was passed over the nickel
charged resins, and unbound proteins were eluted with
buffer B (500 mM NaCl, 20 mM Tris-HCl, 5 mM imida-
zole, pH 7.9) and buffer W (500 mM NaCl, 20 mM Tris-
HCl, 60 mM imidazole, pH 7.9). The AP fusion proteins
were recovered by elution with buffer E (500 mM NaCl, 20
mM Tris-HCl, 1M imidazole, pH 7.9), and were concentrat-
ed using Vivaspin concentrators (Viva science). SDS-
PAGE and Coomassie blue staining confirmed purity (>
90%).
4. Measurement of alkaline phosphatase activity
To measure of the activity of tagged AP of the fusion pro-
tein, conditioned media from stably transfected cells or
from control HEK cells were used. The conditioned media
were heated at 65℃ for 10 minutes to inactivate the
endogenous AP activity, and were then centrifuged at
13,000 rpm for 5 minutes. The supernatant was incubated
with 200 μ L of 1×AP buffer (1.65 mg/mL p-nitro phenyl
phosphate, 0.5 mM MgCl2, 0.1 M diethanolamine (pH 9.8)
for the indicated time, and the amount of color reaction was
measured using a spectrophotometer at a wavelength of 405
nm.
5. Immunohistochemistry
Adult male Sprague-Dawley (p50~70, n=20) were used
for immunohistochemical analysis and the frozen ligand
binding assay. All procedures were performed according to
protocols approved by the Dong-A University Committee
on animal research that follow the guidelines of animal
experimentation established by The Korean Academy of
Medical Sciences. Animals were deeply anesthetized with
an intraperitoneal injection of phentobarbital and were per-
fused with ice-cold PBS (pH 7.2), followed by 4% PFA in
PBS. The brains, spinal cord and dorsal root ganglia were
removed and cryoprotected with 30% sucrose overnight and
cryostat sections (30 μ m) were subsequently prepared. Tis-
sue sections were permeated with 0.2% Triton X-100 in
PBS for 15 minutes. After blocking with 10% normal goat
serum for 1 hour at room temperature, the sections were
incubated with polyclonal anti-TEM7 antibody (1:2500)
overnight at 4℃. Sections were washed three times with
PBS, and then sections were incubated with biotinylated
anti-rabbit IgG (1:200; Vector Laboratories) for 2 h at room
temperature. The sections were washed three times with
PBS and were incubated with a mixture of avidin-biotin in
PBS (1:100) for 1 h at room temperature. The chromogenic
reaction was carried out with 0.05% diaminobenzidine and
0.03% hydrogen peroxide in 0.05 M Tris-Cl buffer (pH
7.4). Sections were dehydrated through a series of graded
alcohol, cleared with xylene, and mounted with Crystal-
mount.
6. Ligand binding assay in tissue sections
Frozen sections were fixed in 4% PFA in PBS for 10
minutes at room temperature, washed twice in PBS for 5
minutes, and were then rinsed in ice-cold Hank’s balanced
salt solution (HBSS) containing 20 mM hepes for 10 min-
utes. The sections were incubated with conditioned medium
containing TEM7-AP or AP for 1 hour at room temperature,
washed twice in HBSS for 10 minutes, and then fixed in AP
fix solution (65% acetone, 3% formaldehyde, 20 mM
Hepes, pH 7.5). Next, the sections were heated in PBS for 2
hours at 65℃, rinsed in AP buffer (100 mM Tris-HCl, pH
Wang et al. TEM 7 and Its Ligand on Spinal Cord and Dorsal Root Ganglion / 679.5, 100 mM NaCl, 5 mM MgCl2) for 10 minutes to inacti-
vate the endogenous alkaline phosphatase. Sections were
developed with a developing solution containing NBT and
BCIP for 5~10 minutes. Sections were then dehydrated
through an ethanol series (70, 90, and 100% ethanol for 2
minutes each) and cleared twice in xylene. The sections
were mounted with Crystalmount and were analyzed using
a Zeiss Axiophot microscope.
Results
1. Localization of TEM7 mRNA in the spinal cord and
dorsal root ganglion
The expression of TEM7 mRNA in the spinal cord and
DRG was analyzed with in situ hybridization using a digox-
igenin-labeled antisense riboprobe. In the spinal cord, the
antisense probe specifically hybridized with TEM7 mRNA
in the neuronal population of the gray matter (Fig. 1B and
1C), whereas the sense probe did not hybridize with TEM7
mRNA (Fig. 1A). The specific signals were mainly
observed in the motor neurons of the ventral horn, but other
neurons in the gray matter, including the dorsal horn,
showed a very low level of TEM7 mRNA expression. The
hybridization signals were observed only in the cytoplasm
but not in the nuclei of the motor neurons (Fig. 1C). The
expression of TEM7 mRNA in the motor neurons was
observed with the same pattern throughout the whole length
of the spinal cord. There were no specific hybridization sig-
nals in the white matter of the spinal cord, meninges and
blood vessels.
In the DRG, TEM7 mRNA was strongly expressed in the
cytoplasm of sensory neurons, but the nuclei of the sensory
neurons were devoid of hybridization signals (Fig. 1E and
1F). The expression of TEM7 mRNA in the DRG was
found in cells with various sizes, implicating nonselective
TEM7 expression in various sensory neurons in the DRG.
The hybridization signals in the satellite cells, Schwann
cells and the spinal nerves were negative. The analysis of
the sections hybridized with the sense probe showed no spe-
cific signals in the DRG (Fig. 1D).
2.  Cloning and characterization of the TEM7
ectodomain
The predicted ectodomain of human TEM7 (eTEM7)
(Fig. 2A) was forcefully expressed in HEK 293 cells. The
expression of eTEM7, which is expected to secrete a ~110
KDa protein composed of a TEM7 ectodomain, alkaline
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Fig. 1. Localization of TEM7 mRNA in the spinal cord and dorsal root ganglion. (A) Sense probe did not label any structures in the
spinal cord. (B, C) TEM7 mRNA expression was observed in the neuronal cells in the gray matter of the spinal cord, especially in th
motor neurons of ventral horn. (C) A representative high magnifcaton of the ventral horn of the spinal cord. (D) Sense probe did not
label any structures in the dorsal root ganglion. (D, E) TEM7 mRNA expression was observed in the sensory neurons in the spinal
cord. (F) A representative high magnification of the sensory neurons. 
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phosphatase (AP; 67 KDa) (Fig. 2A) and Myc/His tags,
occurred not only in cell pellets but also in the culture medi-
um of transiently transfected cells (Fig. 2B). This indicates
that TEM7 is a type I transmembrane protein that has a sin-
gle extracellular domain with the N-terminal outside of the
cell. The transfection of the empty vector (AP-5), which
contains AP as a tag, also produced AP, and AP was
observed both in the cell pellet and supernatant (Fig. 2B).
The activity of the tagged AP of TEM7 ectodomain was
analyzed to demonstrate the utility of this fusion protein for
localizing the expression of the TEM7 ligand. The con-
trolled medium or purified TEM7 proteins were used to test
AP activity. AP and TEM7-AP exhibited high AP activity
as compared with the controlled HEK medium, and the
activity was dose-dependent (Fig. 2C). This finding indi-
cates that the secreted fusion protein is functionally active
and that the construct could be a useful tool for analyzing
the localization profile of the TEM7 ligand.
3. Immunohistochemical analysis of TEM7 expres-
sion in the spinal cord and dorsal root ganglion
A polyclonal anti-TEM7 antibody that was purified with
an affinity column was used to demonstrate the expression
of TEM7 in the spinal cord and DRG at the protein level.
The cerebellar section was used as a positive control for
immunohistochemical analysis since TEM7 mRNA is
known to be highly expressed in the cerebellar Purkinje
cells
2. Consistent with the results of in situ hybridization,
the antibody specifically labeled the cerebellar Purkinje
cells, but not other cells such as granule cells (Fig. 3B).
However, with the omission of the primary antibody, no
cellular structures were labeled (Fig. 3A).
Next, immunohitochemical analysis of TEM7 protein
expression in the spinal cord and DRG was investigated.
The TEM7 antibody labeled neuronal cells especially in the
ventral horn of the spinal cord (Fig. 3C and D). In the white
matter of the spinal cord, the axoplasm seemed to show
weak immunoreactivity. In the DRG, the anti-TEM7 anti-
body specifically labeled the sensory neurons and the
immunoreactivity appeared in the cytoplasm, but not in the
nuclei (Fig. 3E and F). The finding that the expression of
TEM7 protein observed in almost all sensory neurons is
consistent with the finding of TEM7 mRNA expression.
4. Localization of a putative ligand of TEM7 in the
spinal cord and dorsal root ganglion
The expression of the putative ligand of TEM7 was ana-
lyzed by staining the binding site of the recombinant
eTEM7-AP protein. In the spinal cord, the highest eTEM-
AP binding site was observed in the dorsal and ventral root
Fig. 2. Cloning and characterization of tumor endothelial marker 7 (TEM7) ectodomain. (A) Diagrammatic illustration of TEM7 con-
structs bases on amino acid sequence. AP: alkaline phosphatase. (B) The western blot showing the expression of TEM7 constructs in
HEK cells. (C) AP activity assay showing a dose-dependent enzyme activity of tagged AP in the conditioned medium of transfected
293 cells. 
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of the spinal nerves (Fig. 4A). The binding seemed to be
observed in the neurilemma and endoneurium, but not in the
axoplasm, axolemma and myelin sheath. The perineurium
that surrounds the nerve fascicle also showed the strongest
eTEM7-AP binding. In the gray matter, a very low level of
eTEM7-AP binding was observed (Fig. 4A), but the cell
Fig. 3. Immunohistochemical analysis of the TEM7 expression. (A, B) Immunohistochemical stainings with an anti-TEM antibody in
a cerebellar section show the expression of TEM7 in tjje cerebellar Purkinje cells. (B) The omission of the primary antibody did ont
label any structures in the cerebellum. (C~F) The anti-TEM7 antibody specifically labeled the neuronal cell bodies in the ventral
horn o the spinal cord (C, D) and DRG (E, F). (F) The cytoplasm showed intense staining whereas nuclei were devoid of the staining
in sensory neurons. 
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Fig. 4. Localization of a putaive ligand of TEM7 in the spinal cord and dorsal root ganglion. (A) A representative staining of eTEM-
AP in the dorsal root of the spinal nerves. Intense staining was observed in the perineural structures of the dorsal root, but low level
of ligand binding was found in the gray matter. (B) In the while matter of the spinal cord, the ligand binding was observed in the
blood vessels, not neural structures. (C) The strong binding reaction was found in the membrane of sensory neurons and spinal
nerves in the DRG. (D) Perineural structures exhibited an obvious ligand binding.
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bodies of the motor neurons which expressed TEM7 mRNA
did not show any binding of eTEM7-AP. There was no
labeling of eTEM7-AP in the neural structures of the white
matter such as the axon fibers, myelin sheath, and extracel-
lular matrix (Fig. 4B). However, specific binding of
eTEM7-AP is clearly found in the wall of blood vessels
(Fig. 4B). As a negative control, AP protein was used to
stain the sections of the spinal cord. AP did not bind any
structures in the spinal cord (data not shown).
In accordance with the strong reactivity of the neurilem-
mal structure of the spinal nerve roots to eTEM7-AP, the
spinal nerves within the DRG also showed strong eTEM7-
AP binding (Fig. 4C and D). In addition, the plasma mem-
brane of sensory neurons in the DRG had prominent
eTEM7-AP binding activity (Fig. 4C).
5. Developmental expression of TEM7 mRNA and its
putative ligand in the spinal cord and dorsal root
ganglion
Using in situ hybridization, the developmental changes of
TEM7 mRNA expression in the spinal cord and DRG were
analyzed. TEM7 mRNA in the motor neurons of the spinal
cord first appeared on postnatal day 3, but the expression
level was very low (Fig. 5A). A significant increase of
TEM7 mRNA was observed during second postnatal weeks
(Fig. 5B and C). However, the glial cells and endothelial
cells did not show expression of TEM7 mRNA throughout
the postnatal developmental period. In the DRG, expression
of TEM7 mRNA was not observed at postnatal day 3 and
10 (Fig. 5D and E). TEM7 mRNA expression in the sensory
neurons in the DRG was obviously found at postnatal day
20, and expression was confined to the sensory neurons,
and not in other structures (Fig. 5F).
The ligand binding assay showed that the TEM7 binding
activity of the spinal nerves appeared as early as postnatal
day 3 (Fig. 6A). The binding was mainly observed in the
neurilemma of the nerve roots with a similar binding pattern
of eTEM7-AP in the adult spinal cord. The intensity of the
staining in the spinal nerve root did not significantly change
with age (Fig. 6B). The gray matter showed a low level of
ligand binding, but the white matter did not, during the
postnatal period (Fig. 6A and B).
Discussion
The present study is the first to show neuronal expression
Fig. 5. Developmental expression of TEM7 mRNA in the spinal cord and dorsal root ganglion. (A~C) TEM7 mRNA expression in
the spinal cord during postnatal development. The expression of TEM7 mRNA was increased with ages from postnatal day 3 (A). An
obvious TEM7 mRNA expression was observed in the neurons of the gray matter at postnatal day 10 (B) and 20 (C). (D~F) TEM7
mRNA expression in the DRG during postnatal development. The expression of TEM7 mRNA was not observed in the DRG at post-
natal day 3 (D) and 10 (E), but the mRNA expression was found at postnatal day 20 (F). 
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rats. TEM7 mRNA expression was not observed in ependy-
mal cells and endothelial cells of the spinal cord and DRG.
mRNA expression in spinal neurons was demonstrated by
immunohistochemical staining of TEM7 protein in motor
and sensory neurons in the spinal cord and DRG, respective-
ly. These findings indicate that TEM7 may play a specific
role in several neuronal cells of the spinal nervous system.
The predicted structure of TEM7 is that of a type I trans-
membrane protein with a large extracellular region
(ectodomain), a hydrophobic transmembrane domain, and a
short cytoplasmic tail
2. A secreted form of the ectodomain
of type I transmembrane proteins that was fused with a tag
has been made to localize the expression of the correspond-
ing ligands of the ectodomains
16. The present study
employed the same strategy to make a secreted form of
TEM7 ectodomain, and the localization of the putative lig-
and in the spinal cord and DRG was investigated using a
recombinant TEM7 ectodomain. We found that the cover-
ings of spinal nerves, such as the neurilemma, endoneurium
and perineurium, show strong ligand binding to the TEM7
ectodomain. In the DRG, the ligand binding appeared
around the sensory neurons and perineural structures of the
spinal nerves. This finding indicates that the putative ligand
of TEM7 may be a perineurial extracellular matrix (ECM)
protein or a secreted extracellular protein.
The PSI domain consists of ~50 residues of amino acids
and usually contains eight cysteine residues
14. The cysteine
residues are expected to be disulfide bonded. Even though
the presumptive function of the PSI domain is protein-bind-
ing
4,15, the biological function of the PSI domain is still
unknown. Most PSI proteins are highly expressed during
the developmental period in the nervous system, suggesting
a role of the PSI domain-containing protein in the develop-
mental processes such as axon guidance and neuronal
migration. These developmental phenomena are tightly reg-
ulated by the interaction between the cell membrane recep-
tor and ECM proteins. Therefore, the molecular structure of
TEM7 and the localization profile of the putative TEM7 lig-
and suggest a possible role of TEM7 in neural development,
especially in the spinal cord and DRG.
The majority of ECM proteins are structural proteins such
as laminin and fibronectin
19, and ECM proteins play a criti-
cal role in the development of various tissues. In the ner-
vous system, ECM proteins regulate the adhesion and
migration of growth cones and neuronal cells during devel-
opment
20. The present study indicates that the TEM7 ligand
may be a perineurial ECM molecule. In contrast to the
strong staining of TEM7 ligand in the perineural structure
of peripheral spinal nerves, there was no staining in the
white matter of the spinal cord. This finding indicates that
the putative TEM7 ligand is expressed in certain cells of the
peripheral nervous system. It may be possible that Schwann
cells that surround the peripheral nerves will produce the
putative TEM7 ligand. As the basal lamina of Schwann
cells provide important substrates not only for developing
axons but also for regenerating axons
21, the putative
TEM7/ECM ligand interaction may play a role in neurite
growth during development and/or regeneration.
The present study has also revealed that the expression of
TEM7 mRNA in the spinal cord and DRG was develop-
mentally regulated. The expression increased during postna-
tal development. In addition, the ligand binding assay
showed expression of the putative ligand of TEM7 as early
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Fig. 6. Developmental expression of aeputative ligand for TEM7 in the spinal cord and spinal nerves. (A, B) A strong ligand binding
was appeared at postnatal day 3 (A) and 20 (B) in the nerve roots of the spinal nerves. The gray matter of the spinal cord and blood
vessel showed ligand binding sites at early postnatal days.
A Bas postnatal day 3 in the spinal nerve fibers. This finding
indicates that TEM7-ligand interaction plays a role in the
postnatal differentiation of spinal motor neurons and senso-
ry neurons of DRG. TEM7 mRNA expression in the Purk-
inje cells of the cerebellum also increased during postnatal
development (preliminary observation). Therefore, it seems
that TEM7 might play an important role in the postnatal
development of vertebrate neurons. Further studies on the
function of TEM7 and its ligand in spinal nerve develop-
ment would provide an insight into a novel mechanism of
spinal cord development.
Even though the present and previous studies have
revealed the expression profile of TEM7 in the nervous sys-
tem and tumor endothelial cells, the function of TEM7 in
neurons and endothelial cells is completely unknown at pre-
sent. TEM7 seems to be involved in tumor angiogenesis in
concert with other TEMs. It has been recently reported that
TEM8 binds to an ECM protein, collagen alpha 3
22. The
present study has revealed a possibility of an ECM protein
as a TEM7 ligand. It was also reported that the TEM7
ectodomain inhibits fibrin-induced angiogenesis in vitro
23,
indicating a possible interaction between the TEM7
ectodomain and ECM matrix may regulate angiogenesis.
Thus, the identification of TEM7 ligand will shed new light
on the elucidation of TEM7 function in the nervous system
as well as in tumor angiogenesis.
Conclusions
These findings indicate that TEM7 plays a role as a trans-
membrane receptor in neuronal populations of the spinal
cord and DRG.
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